查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726283

全球退伍军人菌检测市场：市场规模、份额、趋势分析（按类型、最终用途和地区）、细分市场预测（2025-2030 年）

Legionella Testing Market Size, Share, & Trends Analysis Report By Type (Water Testing, IVD Testing), By End Use (Microbial Culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

退伍军人菌检测市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球退伍军人菌检测市场预计到 2030 年将达到 5.474 亿美元，2025 年至 2030 年的复合年增长率为 8.2%。

庞蒂亚克热和肺炎等退伍退伍军人菌病发病率的增加是推动市场成长的主要因素之一。根据世界卫生组织 (WHO) 的数据，欧洲、澳洲和美国每年每百万人有 10 至 15 例新病例。

及时进行退伍军人菌检测的趋势日益增长，这是因为这样做可以带来诸如更快康復和改善患者预后等好处。此外，退伍军人菌检测与 PCR 和就地检验等先进诊断技术的结合预计将在预测期内推动该市场的成长。

预计，退伍军人菌检测计画、宣传宣传活动和水安全法规等政府主导的措施将增加全球退伍军人菌病例的检测和管理。例如，在欧洲，严格的法规要求定期对水系统进行退伍军人菌检测，预计将推动对先进退伍军人菌检测方法的需求。

退伍军人菌检测市场：概述

  • 2024 年，欧洲占据全球退伍军人菌检测市场的主导地位，占有 39.0% 以上的份额，这归因于人们对军团菌检测市场的主导地位，占有 39.0% 以上的份额，这归因于人们对退伍军人菌的认识不断提高、医疗保健系统日趋完善、公共卫生保护倡议以及英国和德国等国家的强制性检测规定等因素。
  • 预计预测期内 IVD 测试领域将以显着的复合年增长率成长。
  • 根据最终用途，PCR 部分将在 2024 年占据市场主导地位，收入份额为 37.7%。 PCR 因其高灵敏度和快速处理时间而可以准确、快速地检测细菌。
  • 人口、环境和其他因素导致许多地区退伍军人菌疫情增加，预计将推动需求。
  • 在预测期内，医疗保健系统的显着加强、对及时干预的认识的不断提高以及政府与公共卫生相关的倡议可能会为该行业增加有利的成长机会。

目录

第一章 分析方法与范围

第二章执行摘要

第三章退伍军人菌检测市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 退伍军人菌检测市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章退伍军人菌检测：按类型估算和趋势

  • 按类型分類的仪表板
  • 退伍军人菌检测市场：依类型进行趋势分析
  • 全球退伍军人菌检测市场规模与趋势分析（按类型）（2018-2030 年）
  • 水质检测
    • 市场估计与预测（2018-2030）
  • 体外（IVD）诊断测试
    • 市场估计与预测（2018-2030）

第五章退伍军人菌检测市场：依最终用途的估计和趋势分析

  • 特定于应用程式的仪表板
  • 退伍军人菌检测市场：依最终用途进行变异分析
  • 全球退伍军人菌检测：按最终用途分類的市场规模和趋势分析（2018-2030 年）
  • 微生物培养
  • 直接萤光抗体（DFA）染色
  • PCR
  • 其他的

第六章退伍军人菌检测市场：按地区估计和趋势分析

  • 区域仪表板
  • 各地区市场占有率分析（2024 年及 2030 年）
  • 退伍军人菌检测市场：关键要点、区域
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业热力图分析（2024年）
  • 公司简介
    • Abbott
    • Beckman Coulter, Inc
    • BD
    • Bio-Rad Laboratories, Inc.
    • BIOMERIEUX
    • Eiken Chemical Co., Ltd.
    • Hologic, Inc.
    • Pro Lab Diagnostics Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: GVR-1-68038-372-0

Legionella Testing Market Growth & Trends:

The global legionella testing market size is anticipated to reach USD 547.4 million by 2030 and is expected to experience a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc., the increasing incidence of legionella diseases, such as Pontiac fever and pneumonia, is one of the major factors contributing to the market's growth. According to the World Health Organization (WHO), nearly 10 to 15 new cases per million population are identified every year in Europe, Australia, and the U.S.

The growing inclination towards timely legionella testing can be attributed to advantages such as speedy recovery and improved patient outcome. Additionally, integrating legionella testing methods with advanced diagnostic technologies such as PCR and point-of-care testing are expected to fuel growth of this market in the forecast period.

Government-sponsored initiatives, including legionella testing programs, awareness campaigns, and water safety regulations, are estimated to increase the detection and management of legionella cases globally. For instance, in Europe, stringent regulations mandate regular Legionella testing in water systems, which is expected to boost the demand for advanced Legionella testing methods.

Legionella Testing Market Report Highlights:

  • Europe dominated the global legionella testing market with over 39.0% share in 2024 owing to factors such as increasing awareness regarding legionellosis, sophisticated healthcare systems, public health protection initiatives, and mandatory testing regulations in countries such as the UK and Germany.
  • The IVD testing segment is expected to grow at a significant CAGR over the forecast period.
  • Based on end use, the PCR segment dominated market with revenue share of 37.7% in 2024. PCR enables the precise and rapid detection of bacteria through its high sensitivity and quick turnaround time.
  • Increasing legionella outbreaks recorded in numerous regions driven by factors such as demography, environmental factors and others are expected to drive demand.
  • Significantly enhanced healthcare systems, growing awareness regarding timely interventions, and government initiatives associated with public health are likely to add lucrative growth opportunities to this industry over forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional out
  • 2.3. Competitive Insights

Chapter 3. Legionella Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Legionella Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Legionella Testing: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Legionella Testing Market: Type Movement Analysis
  • 4.3. Global Legionella Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Water Testing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. IVD Testing
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Legionella Testing Market: End Use Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Legionella Testing Market: Application Movement Analysis
  • 5.3. Global Legionella Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Microbial culture
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Direct Fluorescent Antibody (DFA) Stain
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. PCR
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Legionella Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Segment Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Legionella Testing market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. U.K.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.K. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.2.5. Key country dynamics
      • 6.5.2.6. Regulatory framework/ reimbursement structure
      • 6.5.2.7. Competitive scenario
      • 6.5.2.8. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Aregentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 1.1.2. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Beckman Coulter, Inc
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. BD
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Bio-Rad Laboratories, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. BIOMERIEUX
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Eiken Chemical Co., Ltd.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Hologic, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Pro Lab Diagnostics Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Takara Bio Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Thermo Fisher Scientific Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Global legionella testing market, by region, 2018 - 2030 (USD Million)
  • Table 3. Global legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 5. North America legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 7. North America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 9. U.S. legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Mexico legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 13. Mexico legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Europe legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 16. Europe legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 18. Germany legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19. UK legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 20. UK legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21. France legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 22. France legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Italy legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 24. Italy legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Spain legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 26. Spain legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Denmark legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 28. Denmark legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Sweden legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 30. Sweden legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Norway legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 32. Norway legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 36. China legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 37. China legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Japan legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 39. Japan legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40. India legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 41. India legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 43. South Korea legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Australia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 45. Australia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Thailand legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 47. Thailand legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Latin America legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 50. Latin America legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Brazil legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 52. Brazil legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Argentina legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 54. Argentina legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55. MEA legionella testing market, by country, 2018 - 2030 (USD Million)
  • Table 56. MEA legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 57. MEA legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 59. South Africa legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 63. UAE legionella testing market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait legionella testing market, by type, 2018 - 2030 (USD Million)
  • Table 65. Kuwait legionella testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Legionella testing market: market outlook
  • Fig. 10 Legionella testing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Legionella testing market driver impact
  • Fig. 16 Legionella testing market restraint impact
  • Fig. 17 Legionella testing market strategic initiatives analysis
  • Fig. 18 Legionella testing market: type movement analysis
  • Fig. 19 Legionella testing market: type outlook and key takeaways
  • Fig. 20 Water testing market estimates and forecast, 2018 - 2030
  • Fig. 21 IVD testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Legionella testing market: End use movement analysis
  • Fig. 23 Legionella testing market: End use outlook and key takeaways
  • Fig. 24 Microbial culture market estimates and forecasts, 2018 - 2030
  • Fig. 25 Direct Fluorescent Antibody (DFA) Stain market estimates and forecasts,2018 - 2030
  • Fig. 26 PCR market estimates and forecasts,2018 - 2030
  • Fig. 27 Others market estimates and forecasts,2018 - 2030
  • Fig. 28 Global Legionella testing market: Regional movement analysis
  • Fig. 29 Global Legionella testing market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 US market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 46 India market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030